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Abstract
The autosomal dominant spinocerebellar ataxias (SCAs) are a diverse group of neurological
disorders anchored by the phenotypes of motor incoordination and cerebellar atrophy. Disease heterogeneity is appreciated through varying comorbidities: dysarthria, dysphagia, oculomotor and/or retinal abnormalities, motor neuron pathology, epilepsy, cognitive impairment,
autonomic dysfunction, and psychiatric manifestations. Our study focuses on SCA13, which is
caused by several allelic variants in the voltage-gated potassium channel KCNC3 (Kv3.3). We
detail the clinical phenotype of four SCA13 kindreds that confirm causation of the KCNC3R423H
allele. The heralding features demonstrate congenital onset with non-progressive, neurodevelopmental cerebellar hypoplasia and lifetime improvement in motor and cognitive function that
implicate compensatory neural mechanisms. Targeted expression of human KCNC3R423H in
Drosophila triggers aberrant wing veins, maldeveloped eyes, and fused ommatidia consistent
with the neurodevelopmental presentation of patients. Furthermore, human KCNC3R423H
expression in mammalian cells results in altered glycosylation and aberrant retention of the
channel in anterograde and/or endosomal vesicles. Confirmation of the absence of plasma
membrane targeting was based on the loss of current conductance in cells expressing the
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mutant channel. Mechanistically, genetic studies in Drosophila, along with cellular and biophysical studies in mammalian systems, demonstrate the dominant negative effect exerted
by the mutant on the wild-type (WT) protein, which explains dominant inheritance. We demonstrate that ocular co-expression of KCNC3R423H with Drosophila epidermal growth factor
receptor (dEgfr) results in striking rescue of the eye phenotype, whereas KCNC3R423H expression in mammalian cells results in aberrant intracellular retention of human epidermal growth
factor receptor (EGFR). Together, these results indicate that the neurodevelopmental consequences of KCNC3R423H may be mediated through indirect effects on EGFR signaling in the
developing cerebellum. Our results therefore confirm the KCNC3R423H allele as causative for
SCA13, through a dominant negative effect on KCNC3WT and links with EGFR that account
for dominant inheritance, congenital onset, and disease pathology.

Introduction
Patients with dominant cerebellar ataxias display adult-onset, progressive motor incoordination, and cerebellar atrophy [1–5]. Previously, we reported causation of the autosomal dominant disorder SCA13 by mutations in the voltage-gated potassium channel gene, KCNC3
(MIM: 176264, Kv3.3) [6–8]. This tetrameric-delayed rectifier channel facilitates rapid firing
of action potentials in the cerebellum, hippocampus, and brainstem [9–12]. Two allelic forms
of SCA13 [7, 8, 13], p.Arg420His (KCNC3R420H) and p.Phe448Leu (KCNC3F448L) [7], have
been described. Their phenotypes are distinct in that KCNC3R420H results in a slowly progressive, adult-onset ataxia, whereas KCNC3F448L presents in childhood with delayed motor milestones. Screening of ataxia DNA repositories identified a third mutation, g.10693G>A; p.
Arg423His (KCNC3R423H), displaying early-onset SCA13 [14–16]. We report a detailed phenotypic description of this allelic form in a child who presented at age 7 months and in three
additional multigeneration kindreds with multiple affected persons. Features include infantile
onset with delayed gross and/or fine motor milestones, tremor, seizures, cognitive impairment,
gait and/or appendicular ataxia, and dysarthria. Magnetic resonance imaging (MRI) confirms
marked cerebellar hypoplasia as early as 10 months of age. Longitudinal follow-up demonstrates non-progressive cerebellar hypoplasia, with lifetime improvement in motor and cognitive function. Therefore, SCA13R423H may be considered a congenital ataxia causing a fixed
deficit, that is, it is partially overcome by normal development, with eventual accomplishment
of motor and cognitive milestones. We provide supportive evidence for neurodevelopmental
onset through a Drosophila model. Biophysical studies and experiments on cellular localization
also address channel activity and protein trafficking. Our studies also speak to a cellular basis
for dominant inheritance and congenital cerebellar hypoplasia.

Materials and methods
Human genotyping and MRI
Patient DNA was isolated from blood (QIAamp Blood kit) or saliva (Oragene) following written informed consent and approval from the Institutional Review Board of the University of
Florida, Gainesville, Florida (IRB project 484–2007). Written informed consent for minors
was obtained from the next of kin. This study was performed in accordance with the Declaration of Helsinki. All patient-derived sequencing was performed with specific primers (S1
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Table) at the DNA Sequencing Core, University of Florida. Midline sagittal T1-weighted MR
images of patients were collected at multiple institutions.

Plasmid constructs
The human KCNC3WT cDNA was provided by Dr. James L. Rae (Mayo Foundation, Rochester,
Minnesota). Individual mutants (KCNC3R420H, KCNC3R423H, or KCNC3F448L) were generated by
polymerase chain reaction (PCR) with QuikChange Mutagenesis (Agilent Technologies) (S1
Table). The cDNA encoding human KCNC3WT and KCNC3R423H was amplified with primers
appropriate for translation in flies, subcloned into the fly expression vector pUAST, then injected
into yw embryos (Rainbow Transgenic Flies). All constructs were verified by sequencing. PCRamplified human KCNC3WT cDNA and all mutant coding sequences with an enhanced Kozak
site were subcloned into modified green fluorescent protein (GFP) and red fluorescent protein
(RFP) vectors, pcDNA3-Clover and pcDNA3-mRuby2 (Addgene #40259, #40260, provided by
Michael Lin) [17], or Cerulean3-N1 [18] (Addgene #54742, provided by Michael Davidson, S1
Table). Human perbB1-Citrine (EGFRCitrine) was purchased from Addgene (#40266), courtesy
Martin Offterdinger. GFP-JMY-Full length (GFP-junction-mediating and regulatory protein
[JMYGFP]) and GFP-PI4K2A wild-type (PI4K2AGFP) were provided by Theresia E.B. Stradal
(Helmholtz Centre for Infection Research, Braunschweig, Germany) and Tamas Balla (National
Institute of Child Health and Human Development, National Institutes of Health), respectively.
N-Cadherin-EGFP (Addgene plasmid # 18870) was provided by Valeri Vasioukhin.

Drosophila genetics and imaging
Fly stocks were obtained from the Bloomington Drosophila Stock Center (flystocks.bio.indiana.edu, S2 Table). All crosses were at 25˚C unless indicated otherwise. Adult wings (n = 6)
and frozen adult eyes (n = 7) were processed and imaged, as previously described [19].

Cell culture and transfection
Flp-In-CHO (Chinese hamster ovary, Thermo Fisher Scientific) and human glioblastoma U87
cells (ATCC, HTB-14) were cultured in Ham’s F-12 or DMEM (Dulbecco’s modified Eagle’s
medium) (Corning), respectively, with 10% fetal bovine serum (FBS), 25mM glucose, 4mM
glutamine, and pen/strep (penicillin-streptomycin) at 37˚C, 5% CO2. Transient transfections
were carried out using Lipofectamine LTX with Plus reagent (Life Technologies). Total DNA
was kept constant by adding control pcDNA3.1 plasmid.

Immunoblot analysis
Protein from individual 2-day-old flies or CHO or U87 cells was analyzed, as previously
described, [19] with the modification of resolution with 3–8% Tris-acetate gels (Life Technologies). Co-immunoprecipitation experiments were performed with Dynabeads Protein G
(Thermo Fisher Scientific) using α-EGFR (Abcam) for binding and α-EGFR (EMD Millipore)
and α-KCNC3 (Alomone Labs) for detection. Full-length blots are presented in S1 Fig.

Electrophysiology
CHO cells were grown in Iscove’s modified Dulbecco’s medium (Invitrogen), with 10% FBS,
100 units/ml pen/strep, 5% HT supplement (Thermo Fisher Scientific) in 5% CO2 at 37˚C.
Seeded cells were transfected 24h later using Lipofectamine reagent (Invitrogen) with the
mRuby2- or Clover-tagged KCNC3WT or KCNC3R423H constructs. On the recording day,
patch electrodes were pulled from 1.5mm outside diameter borosilicate glass capillaries
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(World Precision Instruments). The resistance of a typical electrode was 2-3M for whole-cell
recording when filled with intracellular solution (in mM) of 97.5 potassium gluconate, 32.5
KCl, 10 HEPES, 5 EGTA, and pH7.2, with KOH. The bath solution consisted of (in mM) 140
NaCl, 5.4 KCl, 1.3 CaCl2, 25 HEPES, 33 glucose, and pH 7.4, with NaOH. Series resistance was
2-4M and was compensated by 80–85%. The data were acquired at 10 kHz and filtered at 5
kHz, using pClamp8 software (Molecular Devices).

Immunofluorescence
Eye-imaginal discs of third instar fly larvae were immunostained using a standard protocol
[20] with bovine serum albumin (BSA) for blocking. Rat α-elav (7E8A10, 1:200), developed by
Gerald M. Rubin, and mouse α-chaoptin (24B10, 1:200), developed by S. Benzer and N. Colley,
were obtained from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa
City, Iowa). CHO cells were transiently transfected with pBKCMV-KCNC3WT, pBKCMVKCNC3R420H, and pBKCMV-KCNC3R423H plasmids, grown on poly-D-lysine–coated coverslips, fixed (4% formaldehyde, 20 min), permeabilized (0.1% Triton X-100, 10 min) and
blocked with 10% BSA. The samples were stained overnight with α-KCNC3 (1:500, Alomone
Labs) at 4˚C, washed with PBS, and subjected to secondary-antibody (Alexa Fluor 594, antirabbit, Molecular Probes) for 1h with samples without the primary processed simultaneously.
CHO cells transiently transfected with Clover-, mCerulean3-, or mRuby2-tagged KCNC3WT,
KCNC3F448L, KCNC3R420H, and KCNC3R423H vectors were imaged 48h post-transfection in
Live Cell Imaging Solution (Molecular Probes) using a Nikon A1 confocal or inverted Olympus IX-HLSH100 microscope. Images were processed using NIS-Elements (Nikon) and Adobe
Photoshop CS6.

Statistical analysis
Statistical analysis with SEM values are presented using an unpaired, two-tailed t-test for significance ( , p<0.001). All analyses were performed using Microsoft Excel and GraphPad
Prism.

Results
Causative inheritance, phenotype and MR imaging associated with the
KCNC3R423H allele
Four multigenerational pedigrees segregating KCNC3R423H provided definitive genetic proof
of causation through complete fidelity in allele segregation of sequenced, affected, and unaffected family members (Fig 1A–1D). Case 423–2 illustrates de novo inheritance in patient II-2.
Midline T1-weighted sagittal MR images demonstrate pronounced cerebellar hypoplasia. A
35-year-old control (Fig 1E) is compared to a 42-year-old affected family member (423–1, II-3,
Fig 1F). T1-weighted MR images of a 10-month-old (423–1, III-1, Fig 1G; inset; age-matched
control) and a 21-month-old (423–2, II-2, Fig 1H) demonstrate severe cerebellar hypoplasia,
consistent with neurodevelopmental onset. Patient 423–2, II-2 presented with a seizure at 7
months and was diagnosed by genotyping and head CT. Review of available patient histories
confirms infantile onset.
The MR images for individuals 423–3, III-2 at 7 and 17 years (Fig 1I and 1J) and 423–4, III4 at 16 and 26 years (Fig 1K and 1L) similarly illustrate severe cerebellar hypoplasia. Strikingly,
these two individuals display minimal age-dependent atrophy in 10-year serial scans (compare
Fig 1I to 1J; 1K to 1L). This contrasts to the KCNC3R420H allele where patients demonstrate
marked progression of cerebellar atrophy over time with concomitant symptom progression
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Fig 1. Pedigrees of the probands’ families and MRI. Four pedigrees (A) 423–1, (B) 423–2, (C) 423–3, and
(D) 423–4, illustrating the inheritance pattern of KCNC3R423H. De novo inheritance in patient II-2 is illustrated
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in 423–2. Midline T1-weighted sagittal magnetic resonance images (MRIs) of (E) a 35-year-old control; (F)
patient 423–1, II-3 at age 42 years; (G) patient 423–1, III-1 at age 10 months (inset shows age-matched
control); (H) de novo patient 423–2, II-2 at age 21 months. Midline T1-weighted sagittal MRIs of (I,J) patient
423–3, III-2 at age 7 and 17 years, respectively; and (K,L) patient 423–4, III-4 at age 16 and 26 years,
respectively, demonstrating the lack of progressive cerebellar hypoplasia and/or atrophy.
https://doi.org/10.1371/journal.pone.0173565.g001

[8]. Furthermore, individual III-2 (423–3, Fig 1C, 1I and 1J) was wheelchair-bound during
early adolescence, transitioning to a walker, then to a cane, and ambulating independently by
late teens, although not completely normally. Patient III-4 (423–4, Fig 1D, 1K and 1L) was initially diagnosed with cerebral palsy and moderate cognitive impairment, but progressed to
unassisted ambulation and/or running and normal-range cognition by age 26 years. A motor
evaluation in 2013 yielded a SARA (Scale for the Assessment and Rating of Ataxia) score [21]
of 13, which remained unchanged at12-month follow-up. Both patients therefore display nonprogressive cerebellar hypoplasia, along with displaying many other activity-dependent
improvements in motor and cognitive milestones. Phenotypic data and ataxic parameters (S3
and S4 Tables), demonstrate uniformity in clinical features within and across families. These
kindreds establish several novel aspects not typical of other SCAs [4, 22–24]: a neurodevelopmental pattern with infantile onset, non-progression of cerebellar atrophy, and clinical symptoms accompanied by cognitive and motor improvement suggestive of compensatory neural
mechanisms despite severe cerebellar hypoplasia.

Expression of human KCNC3R423H in Drosophila melanogaster wing and
eye
Developmental consequences of R423H expression were examined in strains of Drosophila
melanogaster expressing human KCNC3WT and KCNC3R423H controlled by the yeast UAS/
Gal4 expression system [25]. All driver and responder fly strains are summarized in S2 Table.
Expression of KCNC3WT and KCNC3R423H in transgenic flies was verified by immunoblot
(Fig 2A) from individual 2-day-old flies controlled by the ubiquitous daughterless (da)-Gal4
driver [26]. We expressed LacZ, KCNC3WT, or KCNC3R423H in the developing wing (Fig 2B–
2G), along the anteroposterior boundaries extending to the anterior compartment using the
decapentaplegic (dpp)-Gal4 driver. Gal4/KCNC3R423H expression caused complete loss of the
anterior cross vein (ACV) and partial loss of vein L3 (Fig 2G). The flies were kept at 29˚C to
achieve maximal Gal4-transgene expression with minimal effects on viability and fertility [27].
KCNC3R423H expression in the developing wing pouch, using the A9-Gal4 driver [28], resulted
in severely altered wing morphology and vein patterning (Fig 2H–2J).
To test the mutant allele in a developing neuronal lineage, we utilized the eye-specific driver
gmr-Gal4 [29] for expression throughout eye development. KCNC3R423H expression displayed
marked eye dysmorphology and a profound reduction in size (Fig 2M), disrupted ommatidial
organization, fused ommatidia, and malformed eye bristles (Fig 2P and 2S) compared to those
of a normal eye phenotype in KCNC3WT and a control LacZ (Fig 2K, 2L, 2N, 2O, 2Q and 2R).
Sagittal sections of the KCNC3WT eyes illustrate regular arrangement of each lens at the apex of
the elongated ommatidium, in contrast with the disrupted pattern observed in the
KCNC3R423H eyes (S2A and S2B Fig). In addition to the adult eye, we stained the eye imaginal
discs from wandering third instar larvae for the pan-neuronal marker elav [30]. Control
KCNC3WT larval imaginal discs revealed expected organized ommatidia (S2C Fig), whereas
KCNC3R423H larvae showed disorganized and fused ommatidia with maldeveloped smaller
ommatidial clusters (S2D Fig). Detection of chaoptin, a photoreceptor cell- and axon-specific
membrane protein required for cell morphogenesis [31], illustrates normal organization of the
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Fig 2. Expression of human KCNC3WT and KCNC3R423H in the Drosophila wing and eye. (A) Cropped
immunoblot using antibodies directed against mammalian KCNC3 and Drosophila tubulin illustrates da-Gal4
expression of the indicated transgenes (human KCNC3WT, KCNC3R423H, or β-galactosidase (LacZ)) under
control of the ubiquitous da-Gal4 driver (full-length blot shown in S1 Fig). (B-D) Wing images from adult flies
maintained at 29˚C, where the dpp-Gal4 drives expression of LacZ, KCNC3WT, or KCNC3R423H in the
anterioposterior border of the wing. (E-G) Magnified images showing loss of the anterior crossvein (ACV [E];
red arrow [G]) and disruption of the longitudinal vein L3 as a consequence of KCNC3R423H expression (dotted
brackets [G]). (H-J) Wing images from adult flies where A9-Gal4 drives expression in the wing compartment.
(K-M) Eye images from adult flies where gmr-Gal4 drives expression of LacZ, KCNC3WT, or KCNC3R423H,
demonstrating small, maldeveloped eyes in the mutant. (N-P) Scanning electron microscopy images of whole
eyes from LacZ, KCNC3WT, or KCNC3R423H flies. Yellow square highlights region of eye shown at high
resolution (Q-S).
https://doi.org/10.1371/journal.pone.0173565.g002

axon bundle from the ommatidia to the brain in the KCNC3WT larvae (S2E Fig), whereas
KCNC3R423H larvae displayed disorganized and diminished axonal projections (S2F Fig).

KCNC3R423H intracellular location and biophysics
We recently reported that the KCNC3R420H allele [7, 8, 32] displayed altered post-translational
modifications with aberrant retention in the Golgi [19]. CHO cells, with no detectable endogenous KCNC3, transiently transfected with human KCNC3WT (Fig 3A), show normal plasma
membrane localization by immunofluorescence. In contrast, cells expressing KCNC3R423H
(Fig 3C; compare to KCNC3R420H in Fig 3B), demonstrate aberrant trafficking with strong
perinuclear staining analogous to the KCNC3R420H allele [19]. As illustrated with other representative cells (Fig 3B and 3C insets) aberrant trafficking is consistently observed with both
mutants. To corroborate the aberrant trafficking, we then generated C-terminal Clover-tagged
vectors [17] harboring. Confocal microscopy illustrates normal plasma membrane localization
(Fig 3D) for KCNC3WT, in contrast to absent plasma membrane localization and clear perinuclear retention for each mutant (Fig 3E and 3F). This aberrant trafficking is found in all cells
from multiple independent transfection experiments. For further comparison, we also
expressed the Clover-tagged SCA13 mutation from a French pedigree, KCNC3F448L, which displays normal plasma membrane trafficking (Fig 3G), although associated with altered biophysical properties [7].
To demonstrate that protein overexpression was not responsible for aberrant localization,
we show that over about an 8-fold range of transfected plasmid concentrations, with vectors
harboring human KCNC3WT and KCNC3R423H C-terminally tagged with mCerulean3 [18],
KCNC3R423H-mCerulean3 remains intracellularly localized, with no detectable plasma membrane
trafficking, in contrast to normal localization with equivalent concentrations of the KCNC3WT
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Fig 3. KCNC3R423H displays aberrant intracellular trafficking, glycosylation, and failure to express current
in cell culture. (A-C) Immunofluorescence of CHO cells expressing human KCNC3WT, KCNC3R420H, or
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KCNC3R423H using a KCNC3 antibody. Insets illustrate other representative cells from each transfection. (D-G)
Confocal fluorescence images of CHO cells transiently expressing Clover-tagged human KCNC3WT, KCNC3R420H,
KCNC3R423H, or KCNC3F448L. Fluorescence images of CHO cells transiently expressing (H-J) an ER marker,
SIGMAR1CFP with KCNC3R423H-mRuby2; (K-M) an anterograde vesicle marker, JMYGFP with KCNC3R423H-mRuby2;
and (N-P) a Golgi–endosome vesicle marker, PI4K2AGFP with KCNC3R423H-mRuby2. (N) Boxed area is magnified in
(Q-S), with inset in S clearly demonstrating intravesicular retention of KCNC3R423H-mRuby2. Cropped immunoblot of
human KCNC3WT, KCNC3R423H, or KCNC3R420H expressed in (T) CHO cells or (U) human U87 glioblastoma cells
illustrating aberrant glycosylation for both causative mutant alleles (full-length blot shown in S1 Fig). Representative
currents evoked by commands to potentials between −80 mV and +70 mV, recorded in CHO cells expressing (V)
KCNC3WT-Clover or (W) KCNC3R423H-Clover.
https://doi.org/10.1371/journal.pone.0173565.g003

allele (S3 Fig). This finding clearly demonstrates that channel mis-trafficking is not attributable
to protein expression levels.
To determine the intracellular localization of the mutant channel, we used fluorescently
tagged markers of endoplasmic reticulum (ER), Golgi, and intracellular vesicles. Sigma receptor 1 (SIGMAR1) is a highly conserved, transmembrane chaperone protein located in the ER
membrane [33]. On co-expression of the cyan fluorescent protein (CFP) tagged SIGMAR1
(SIGMAR1CFP) with KCNC3R423H-mRuby2 (Fig 3H–3J), we observed no co-localization, which
rules out aberrant retention in the ER. JMY is linked to cytosolic actin assembly and acts as a
DNA damage-induced transcriptional co-activator of p53 [34, 35]. Recently, Schlüter et al.
[36] also demonstrated JMY’s role in vesicular trafficking at the trans-Golgi network through
actin-dependent elongation and/or tubulation of anterograde vesicles. Co-expression of
JMYGFP with KCNC3R423H-mRuby2 resulted in co-localization (Fig 3K–3M) in vesicular structures, implying the retention of KCNC3R423H in trafficking vesicles. PI4K2A, a membranebound phosphatidylinositol-4 kinase, localizes to the trans-Golgi network (TGN) and early
endosomes [37, 38] and is responsible for phosphorylation of phosphatidylinositol (PI) to
phosphatidylinositol 4-phosphate (PI4P), a critical lipid in endocytosis, Golgi function, protein
sorting, and membrane trafficking [39]. Co-expression of KCNC3R423H-mRuby2 with
PI4K2AGFP clearly demonstrates that the mis-trafficked mutant channel accumulates in the
intravesicular space of PI4K2AGFP–positive vesicles (Fig 3N–3S). These results suggest that
KCNC3R423H is retained in the interior of anterograde or endosomal vesicles rather than being
incorporated into the vesicular membrane.
As an integral membrane protein, N-glycans are added to the nascent KCNC3 protein in
the ER with trimming of the oligosaccharide precursor, a critical quality-control measure for
proper glycoprotein folding and vesicular trafficking through the Golgi en route to the plasma
membrane. The expression of human KCNC3R423H in CHO (Fig 3T) or U87 cells (Fig 3U)
demonstrates altered glycosylation patterns consistent with our previous studies on
KCNC3R420H [19].
As a voltage-dependent potassium channel, KCNC3/Kv3.3 displays high activation thresholds with fast activation and deactivation kinetics, conveying the property of sustained trains
of high-frequency action potentials in neurons expressing them [40]. To assess the functional
consequences of the KCNC3R423H mutation, we performed electrophysiology in CHO cells
transiently expressing the human KCNC3WT or KCNC3R423H channels. For KCNC3WT, Fig
3V illustrates the slow inactivating outward current evoked during application of depolarizing
voltage steps (increments of 10 mV from −80 mV to +70 mV). In contrast, cells expressing the
KCNC3R423H channels demonstrate the complete absence of current conductance by the
mutant channel over the same voltage range (Fig 3W), consistent with aberrant glycosylation
and intracellular retention.
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KCNC3R423H has a dominant effect on KCNC3WT
The consequences of an increased dosage of the KCNC3R423H allele were determined by creating flies harboring 2× copies of KCNC3R423H, resulting in a more severe eye phenotype entirely
lacking ommatidia (Fig 4B compared to Fig 4A). Moreover, simultaneous expression of exogenous KCNC3WT with KCNC3R423H did not overcome the eye phenotype (Fig 4C compared to
Fig 4A), which implicates the dominant nature of the R423H allele. Similarly, KCNC3R423H
self-cross, driven by dpp-Gal4 in the wing, led to disruption of veins L2, L3, and ACV in the
wing (Fig 4E compared to Fig 4D), whereas co-expression of KCNC3WT with KCNC3R423H
resulted in a phenotype similar to KCNC3R423H alone (Fig 4F compared to Fig 4D). Studies in
the eye and wing thus support the strong dominant negative effects exerted by KCNC3R423H.
KCNC3 functions as a tetrameric voltage-gated potassium channel [41, 42]. This disease
presents as an autosomal dominant phenotype, [7, 32] presumably resulting from the formation of a heterotetramer composed of WT and mutant monomers. We have determined the
probabilities of heterotetramer interactions based on WT:423 ratios of 1:1 to 6:1 (S4A and S4B
Fig). Biophysical studies of CHO cells co-expressing KCNC3WT: KCNC3R423H at a ratio of 1:1
demonstrate a significant reduction in current amplitude and mean current densities compared to those of cells expressing KCNC3WT alone (Fig 5A, 5B and 5C), thereby showing a
dominant electrophysiological effect. Studies using other model systems have implied that the
dominant phenotypic effects manifested by KCNC3R423H and KCNC3R420H mutations are
based on alterations in channel electrophysiology [43]. These results are not supported by our
data [19] (Fig 3A–3S), which demonstrate that neither mutation is appreciably trafficked to
the plasma membrane. To address the mechanism underlying the dominant phenotypic effects
of KCNC3R423H, we also used differentially C-terminally labeled mutant and WT channels to
explore intracellular trafficking and tetrameric protein association. KCNC3WT-Clover was coexpressed with KCNC3R423H-mRuby2 in cells at ratios from 1:1 to 6:1 and visualized by confocal
microscopy (Fig 5D–5S). As expected, KCNC3WT-Clover alone traffics normally to the plasma
membrane (Fig 5D), whereas KCNC3R423H-mRuby2 alone displays complete retention in intracellular vesicles (Fig 5G). Co-expression with increasing ratios of KCNC3WT: KCNC3R423H
demonstrates complete co-localization (Fig 5H–5S) suggestive of tetrameric co-assembly,
along with complete retention of the KCNC3WT protein in the same intracellular vesicles even
at a ratio of 6:1 (Fig 5Q–5S).

dEgfr rescues the Drosophila KCNC3R423H eye phenotype
To identify the Drosophila pathway(s) affected by KCNC3R423H, we evaluated modifiers of the
mutant phenotypes upon co-expression with a series of eye and wing specific determinants,
including dEgfr, Ras, Rolled (mitogen-activated protein kinase [MAPK]) and Notch [44–46]
(S2 Table). Effects of Egfr overexpression (UAS-Egfr.B) [47] were evaluated on a gmr-Gal4
(Fig 6A and 6B) or gmr-Gal4, UAS-KCNC3R423H background (Fig 6C and 6D). Elevated
expression of dEgfr with the UAS-Egfr.B allele resulted in a striking rescue of the KCNC3R423H
eye phenotype (Fig 6D), which supports a link between the mutant voltage-gated potassium
channel and Egfr or its downstream signaling pathway. To further demonstrate interactions
between KCNC3R423H and Egfr in eye development, we expressed two dEgfr RNAi strains in
the context of KCNC3R423H at 25˚C (S5A–S5F Fig). Due to lower Gal4 expression at 25˚C, the
KCNC3R423H allele displayed no overt eye pathology (S5D Fig), with the dEgfr RNAi strains displaying only minor effects on ommatidia organization (S5B and S5C Fig). However, co-expression of KCNC3R423H and dEgfr RNAi transgenes resulted in a reduction in eye size (S5E and
S5F Fig) reminiscent of the KCNC3R423H phenotype at 29˚C (Fig 2M).
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Fig 4. KCNC3R423H causes dominant effects on KCNC3WT in Drosophila. Eye images from gmr-Gal4 flies
expressing (A) KCNC3R423H; (B) two copies of KCNC3R423H; and (C) KCNC3WT with KCNC3R423H. Wing
images from dpp-Gal4 flies expressing (D) KCNC3R423H; (E) two copies of KCNC3R423H; and (F) KCNC3WT
with KCNC3R423H. Red arrows and boxes (dashed lines) indicate areas of aberrations.
https://doi.org/10.1371/journal.pone.0173565.g004

Egfr signaling in Drosophila involves a linear pathway with equivalent mammalian orthologs as summarized in S6 Fig. We thus evaluated overexpression of downstream mediators Ras
(S7B and S7F Fig) and Rolled (MAPK, S7C and S7G Fig), which displayed little effect on the
KCNC3R423H eye phenotype. These data imply that the mutant channel may be impairing Egfr
signaling at the level of the receptor, consistent with KCNC3R423H dominant effects (Figs 4 and
5). During the third instar larval stage, cells arrest in the eye imaginal disc and constrict at the
disc’s posterior edge to form the morphogenetic furrow (MF) [48, 49]. The MF then travels
anteriorly, where Notch signaling establishes specification of the initial R8 photoreceptor neurons as the founding cells of the developing ommatidia. Signaling from the Egfr pathway leads
to the recruitment of the remaining photoreceptor cells in a pairwise manner (R2/5, R3/4, R1/
6, and finally R7), along with non-neuronal cone and pigment cells [46]. Therefore, we also
evaluated the effects of Notch overexpression and found no effect on the KCNC3R423H eye phenotype (S7D and S7H Fig), further supporting specificity for the interaction of the mutant
potassium channel allele with Egfr. The connection with EGFR was further corroborated with
experiments in the wing demonstrating that co-expression of Egfr-RNAi and KCNC3R423H
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Fig 5. KCNC3R423H causes dominant electrophysiological and trafficking effects on KCNC3WT. (A)
Representative currents evoked by a step from −70 mV to +70 mV in CHO cells expressing KCNC3WT-Clover or
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KCNC3R423H-Clover, and in those transfected with both constructs KCNC3WT-Clover:KCNC3R423H-mRuby2 in a 1:1
ratio. (B) Mean current densities recorded in CHO cells expressing either wild-type KCNC3WT-Clover (n = 7) or
KCNC3R423H-Clover (n = 5) and in those expressing both KCNC3WT-Clover: KCNC3R423H-mRuby2 (1:1) constructs
(n = 6). Current density was calculated by dividing the peak current evoked by a step from −70 to +70 mV by
cell capacitance. Values are shown as mean±SEM, and significance was tested using a one-way ANOVA.
(C) Current-voltage relations for cells in the three conditions shown in (A) and (B). Confocal fluorescence
microscopy of cells expressing KCNC3WT-Clover (D) or KCNC3R423H-mRuby2 (G) individually, with no channel
bleed-through (E,F). (H-S) Confocal fluorescence microscopy of cells co-expressing KCNC3WT-Clover and
KCNC3R423H-mRuby2 at ratios of 1:1 to 6:1 (KCNC3WT:KCNC3R423H) showing co-localization and intracellular
retention of both proteins, even at the highest concentration of KCNC3WT. The total amount of DNA used in the
co-transfection experiments was kept constant across ratios by adding control plasmid pcDNA 3.1.
https://doi.org/10.1371/journal.pone.0173565.g005

causes more significant abnormalities in wing vein development than either strain alone (Fig
6E–6G). These results thus provide evidence that the developmental effects of KCNC3R423H
expression may be mediated through disruption of EGFR signaling.

KCNC3R423H allele contributes to aberrant trafficking of EGFR
To test whether the potassium channel directly interacts with EGFR in mammalian cells, we
transiently transfected U87 cells, known to express EGFR [50], with either human KCNC3WT
or KCNC3R423H.Cellular lysates were subjected to immunoprecipitation with EGFR-specific
antibodies. As expected, U87 cells expressed EGFR (Fig 7A, left panel), while immunoblot
analyses of the identical immunoprecipitation lysates showed no detectable bands in either the
KCNC3WT or KCNC3R423H transfected cells (Fig 7A, right panel), despite clear overexpression
of KCNC3 (Fig 7B).
With no apparent direct protein-protein interaction, we examined the potential influence of
aberrant KCNC3R423H cellular trafficking on EGFR transit through the ER/Golgi to the plasma

Fig 6. Effects of Egfr on the KCNC3R423H Drosophila eye and wing phenotypes. (A-C) gmr-Gal4–driven
expression of controls LacZ, Egfr, and KCNC3R423H individually. (D) Co-expression of Egfr and KCNC3R423H
shows rescue of the mutant phenotype. (E-G) dpp-Gal4–driven expression of KCNC3R423H and Egfr-RNAi,
individually and co-expressed. Red arrows and boxes (dashed lines) indicate areas of aberrations.
https://doi.org/10.1371/journal.pone.0173565.g006
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Fig 7. KCNC3R423H causes aberrant EGFR trafficking resulting in intracellular retention. (A) Immunoblot
with α-EGFR illustrating positive immunoprecipitation (IP) of EGFR in the eluent from beads bound to anti-EGFR

PLOS ONE | https://doi.org/10.1371/journal.pone.0173565 May 3, 2017

14 / 21

Pathological mechanisms associated with a congenital non-progressive SCA13 causative mutation

antibody (left panel), with absence of KCNC3 in the same complex (α-KCNC3, right panel). (B) Immunoblot (αKCNC3) showing presence of KCNC3 in the lysate. (C-E) Confocal fluorescence images of cells co-expressing
KCNC3WT-mCerulean3:human EGFRCitrine (5:1 ratio), showing membrane localization for both proteins. (F-H)
Representative cell co-expressing KCNC3R423H-mCerulean3: human EGFRCitrine (5:1 ratio) showing that both
proteins do not reach the plasma membrane and are retained in intracellular vesicles. Insets provide additional
examples. (I-K) Representative cell co-expressing KCNC3R423H-mCerulean3:human EGFRCitrine (4:1 ratio) also
showing aberrant trafficking for both proteins. Insets magnify the co-localization of the two proteins in vesicles.
(L-N) Representative cell co-expressing KCNC3R423H-mCerulean3:human EGFRCitrine (2:1 ratio) showing both
plasma membrane trafficking and intracellular retention for EGFR. (O-Q) Confocal fluorescence images of
cells co-expressing KCNC3R423H-mCerulean3:human EGFRCitrine (1:1 ratio) also demonstrating membrane and
intracellular trafficking for EGFR with continued intracellular retention for KCNC3R423H. The total amount of DNA
used in the co-transfection experiments was kept constant across ratios by adding control plasmid pcDNA 3.1.
https://doi.org/10.1371/journal.pone.0173565.g007

membrane. Cells were co-transfected with KCNC3WT-mCerulean3 or KCNC3R423H-mCerulean3 and
with varying concentrations of a Citrine-tagged human EGFR [51] construct, using KCNC3:
EGFR molar ratios from 5:1 to 1:1 (Fig 7C–7Q). Representative confocal Z-stacks of cells
expressing both KCNC3WT and EGFR (Fig 7C–7E) illustrate that, despite an excess of
KCNC3WT (5:1), both proteins trafficked normally to the plasma membrane. Conversely, coexpression of KCNC3R423H and EGFR at ratios of 5:1 (Fig 7F–7H) and 4:1 (Fig 7I–7K) reproducibly led to aberrant trafficking of EGFR with sequestration in intracellular vesicles that
co-register with KCNC3R423H (Fig 7H and 7K). As the molar ratio of KCNC3R423H:EGFR is
decreased to 2:1 (Fig 7L–7N), EGFR is found both intracellularly sequestered and at the plasma
membrane. At a ratio of 1:1, EGFR traffics normally to the plasma membrane, while in some
cells the receptor continues to intracellularly co-register with KCNC3R423H (Fig 7O–7Q). The
titration was repeated with KCNC3R423H tagged with a different fluorescent protein, mRuby2,
co-expressed with EGFRCitrine at ratios of 3:1 (S8 Fig). These results further illustrate that complete normal trafficking of the receptor to the plasma membrane is achieved only with reduction
of the molar ratio of KCNC3R423H:EGFR to 0.7:1. To determine whether the mutant channel
could cause aberrant trafficking of other membrane proteins, we co-expressed KCNC3WT or
KCNC3R423H with N-cadherin (Cadherin-2 [CDH2]) fused with eGFP [52] at molar ratios of
3.5:1 and 2.5:1, with no effects on plasma membrane localization for cadherin (S9 Fig). Together
with the rescue of the Drosophila eye phenotype (Fig 6E and 6G), these observations strongly
implicate a specific link between this causative mutant allele and EGFR.

Discussion
Previous studies [43, 53, 54] identified KCNC3R423H by screening index ataxia patients from
US [15] and European [14, 16] DNA repositories. Our analysis of four pedigrees (3 US, 1
Swedish) unequivocally demonstrates SCA13 causation for this allele. The unifying endophenotype includes infantile onset, non-progressive cerebellar hypoplasia, lifetime improvement
of motor and cognitive function, bradyphrenia, dysarthria, tremor, and the classic SCA feature
of limb, truncal, and gait ataxia (S3 and S4 Tables). A striking clinical observation is the timeand activity-dependent improvement in motor and cognitive function, despite severe congenital cerebellar hypoplasia (Fig 1).
To address this unique clinical pathology, we have developed fly and cellular models to
investigate the underlying developmental, cellular, and biochemical events illuminating mechanisms of neurodevelopmental onset and dominant inheritance. Without SCA13 autopsy
specimens, our current understanding of human pathology derives from clinical history and
MRI-based cerebellar hypoplasia.
Drosophila eye differentiation has previously been used to model alleles causative in SCAs
[23, 55–58]. Consistent with neurodegeneration, all these mutant alleles display large,
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disorganized eyes or a “rough eye” phenotype. In contrast, overexpression of human
KCNC3R423H in adult flies results in small, maldeveloped eyes exhibiting fused and disorganized ommatidia and disordered eye bristles, along with aberrant wing veins and shrunken
wing formation, which suggests a neurodevelopmental effect. Consistent with a congenital
phenotype, expression of KCNC3R423H in third instar larvae caused disturbed patterning and
fusion of ommatidial clusters, axonal bundle thinning, and reduced photoreceptor cell clusters.
Collectively, these data support the neurodevelopmental nature of KCNC3R423H in SCA13
patients.
Normal trafficking of plasma membrane–targeted proteins involves glycosylation and folding in the ER compartment believed to be followed by vesicular transport to the Golgi for glycan trimming and protein sorting [59]. Vesicles originating at the trans-Golgi network are
involved in anterograde transport to the plasma membrane through close association with
microtubules and actin filaments [60–62]. Our data show that KCNC3R423H expressed in cell
culture is abnormally glycosylated and does not reach the plasma membrane. Co-localization
results demonstrate that KCNC3R423H is sequestered in the intravesicular space of either anterograde or endosomal vesicles based on striking co-expression with PI4K2A, a vesicular membrane marker. Consistent with this intracellular sequestration are biophysical studies
unequivocally demonstrating absent current conductance in cells expressing this mutation.
These data provide an explanation for the deleterious effects of the mutation but alone do not
address the dominant inheritance.
To explore the dominant phenotype in SCA13 in light of its tetrameric nature, we calculated the probabilities of tetramer formation relative to expressed ratios of KCNC3WT and
KCNC3R423H (S4A and S4B Fig). We provide three lines of experimental evidence that
KCNC3R423H exerts a strong dominant negative effect on KCNC3WT monomers (Figs 4 and
5). Self-crosses in the fly eye and wing show that KCNC3WT does not overcome the effects of
the mutant allele, along with co-expression in cell culture, where at a ratio as high as 6:1 (WT:
R423H), KCNC3WT remains mis-trafficked and intracellularly localized. Functionally, these
data are further supported with biophysical data showing that <20% current conductance is
detectable at a 1:1 ratio of WT:R423H. Collectively, these data form a strong basis for dominant inheritance but do not address the neurodevelopmental phenotype.
The Egfr and Notch morphogenetic pathways are prominent pathways involved in Drosophila eye and wing development [46, 63, 64]. dEgfr is required for recruitment of neuronal
and non-neuronal cells in the ommatidium [29, 65]. Because the profound KCNC3R423H eye
phenotype can be almost completely rescued by elevated Egfr expression and R423H/EgfrRNAi co-expression accentuates wing malformations, a direct or indirect association is
strongly implicated between KCNC3 and Egfr, as well as a link between this potent growth factor receptor and cerebellar hypoplasia. Consistent with the fly data, co-expression of EGFR
with KCNC3R423H in mammalian cells leads to aberrant intracellular retention of EGFR that
co-registers in vesicles with the mutant channel, the same anterograde and/or endosomal vesicles positive for PI4K2A. Normal EGFR plasma membrane localization is overcome only with
a decrease in the concentration of the mutant channel below a ratio of 1:1. Negative co-immunoprecipitation data confirms that the intracellular retention of EGFR by KCNC3R423H is not
likely to be dependent on a direct protein-to-protein interactions. Therefore, our current
hypothesis involves the intracellular sequestration of EGFR through yet unknown effects of
KCNC3R423H in anterograde or endosomal vesicles during cerebellar development. This
hypothesis can be rationalized in part by previous studies in rats proving the presence of
EGFR in Purkinje cells during late cerebellar development [66, 67]. It is also relevant to note
that PI4K2A has been shown to co-localize with protein markers of the late endosome and is
required for endocytic trafficking and degradation and/or downregulation of EGFR [68].
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Future studies to address the interplay of KCNC3R423H, EGFR, and PI4K2A will provide
important insights into the mechanisms governing normal cerebellar development and cerebellar hypoplasia in SCA13.
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